Journal article
5T4 oncofoetal glycoprotein: an old target for a novel prostate cancer immunotherapy
- Abstract:
-
The tumour-associated antigen 5T4 is an attractive target for cancer immunotherapy. However to date, reported 5T4-specific cellular immune responses induced by various immunisation platforms have been largely weak or non-existent. In the present study, we have evaluated a heterologous prime boost regime based on the simian adenovirus ChAdOx1 and modified vaccinia virus Ankara (MVA) expressing 5T4 for immunogenicity and tumour protective efficacy in a mouse cancer model. Vaccination-induced im...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 2.4MB)
-
- Publisher copy:
- 10.18632/oncotarget.17666
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
+ National Institutes for Health Research
More from this funder
Grant:
Oxford Biomedical Research Centre, UK (IR
+ European Union
More from this funder
Grant:
Seventh Framework Programme under grant agreement No. 602705 ( (FC, EP)
Bibliographic Details
- Publisher:
- Impact Journals Publisher's website
- Journal:
- Oncotarget Journal website
- Volume:
- 8
- Issue:
- 29
- Pages:
- 47474-47489
- Publication date:
- 2017-05-07
- Acceptance date:
- 2017-04-19
- DOI:
- ISSN:
-
1949-2553
- Source identifiers:
-
698059
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:698059
- UUID:
-
uuid:0a97069a-13de-4276-bef3-0adc8e6b4cc3
- Local pid:
- pubs:698059
- Deposit date:
- 2017-07-03
Terms of use
- Copyright holder:
- Cappuccini et al
- Copyright date:
- 2017
- Notes:
-
Copyright © Cappuccini et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC-BY),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record